Literature DB >> 23333139

Why are we still using coronary bare-metal stents?

Marie-Claude Morice, Philip Urban, Samantha Greene, Gerhard Schuler, Bernard Chevalier.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23333139     DOI： 10.1016/j.jacc.2012.11.049

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  10 in total

1.  Coronary stenting: A matter of revascularization.

Authors:  Aldo Bonaventura; Fabrizio Montecucco; Luca Liberale
Journal:  World J Cardiol       Date:  2017-03-26

Review 2.  Is it time to take bare metal stents off the catheter laboratory shelf?

Authors:  George Kassimis; Adrian P Banning
Journal:  Eur Heart J       Date:  2016-06-09       Impact factor: 29.983

3.  Submucosal Hematoma of the Sigmoid Colon as a Complication of Anticoagulation Treatment.

Authors:  Huijiang Zhou; Shuai Wang; Lin Zhu
Journal:  J Gastrointest Surg       Date:  2018-03-12       Impact factor: 3.452

4.  Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy: A Meta-analysis.

Authors:  Rahman Shah; Sunil V Rao; Samuel B Latham; David E Kandzari
Journal:  JAMA Cardiol       Date:  2018-11-01       Impact factor: 14.676

Review 5.  Bleeding avoidance strategies in percutaneous coronary intervention.

Authors:  Davide Capodanno; Deepak L Bhatt; C Michael Gibson; Stefan James; Takeshi Kimura; Roxana Mehran; Sunil V Rao; Philippe Gabriel Steg; Philip Urban; Marco Valgimigli; Stephan Windecker; Dominick J Angiolillo
Journal:  Nat Rev Cardiol       Date:  2021-08-23       Impact factor: 32.419

Review 6.  Clinical utility of platinum chromium bare-metal stents in coronary heart disease.

Authors:  Claudia Jorge; Christophe Dubois
Journal:  Med Devices (Auckl)       Date:  2015-08-27

7.  Early Clinical Experience with a Polymer-Free Biolimus A9 Drug-Coated Stent in DES-Type Patients Who Are Poor Candidates for Prolonged Dual Anti-Platelet Therapy.

Authors:  Tim Kinnaird; Mehmood Butt; Fairoz Abdul; Khaled Yazji; Ahmed Hailan; Sean Gallagher; Nicholas Ossei-Gerning; Alexander Chase; Anirban Choudhury; David Smith; Richard Anderson
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

8.  Evaluation of safety and efficacy of NexGen - an ultrathin strut and hybrid cell design cobalt-chromium bare metal stent implanted in a real life patient population - the Polish NexGen Registry.

Authors:  Krzysztof Milewski; Paweł Gąsior; Stefan Samborski; Piotr P Buszman; Aleksandra Błachut; Adam Wojtaszczyk; Adam Młodziankowski; Artur Mendyk; Marek Król; Wojciech Wojakowski; Paweł E Buszman
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-08-19       Impact factor: 1.426

9.  Should Percutaneous Coronary Intervention be the Standard Treatment Strategy for Significant Coronary Artery Disease in all Octogenarians?

Authors:  George Kassimis; Grigoris V Karamasis; Athanasios Katsikis; Joanna Abramik; Nestoras Kontogiannis; Matthaios Didagelos; Dimitrios Petroglou; Christodoulos E Papadopoulos; Leonidas Poulimenos; Vassilios Vassilikos; Ioannis Kanonidis; Tushar Raina; Antonios Ziakas
Journal:  Curr Cardiol Rev       Date:  2021

10.  Polymer-free Biolimus-A9 coated thin strut stents for patients at high bleeding risk 1-year results from the LEADERS FREE III study.

Authors:  Franz R Eberli; Hans-Peter Stoll; Philip Urban; Marie-Claude Morice; Philippe Brunel; Luc Maillard; Janus Lipiecki; Stephane Cook; Jacques Berland; Thomas Hovasse; Didier Carrie; Diana Schütte; Sara Sadozai Slama; Philippe Garot
Journal:  Catheter Cardiovasc Interv       Date:  2021-07-09       Impact factor: 2.585
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.